Harmony Biosciences Holdings HRMY
NASDAQ HRMY
$39.64 +0.07 (+0.18%)
At close: Oct 2, 2026 · 4:00 PM EDT

Harmony Biosciences Holdings (HRMY) Income towards Parent Company (2019 - 2026)

Updated

Harmony Biosciences Holdings' Income towards Parent Company came in at $75.43 million for Q2 2026, up 89.6% from $39.78 million a year earlier and up 132.2% from the prior quarter.

Analysis

Harmony Biosciences Holdings (HRMY) Income towards Parent Company (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Harmony Biosciences Holdings reported Income towards Parent Company of $181.27 million, up 0.2% year-over-year; for FY2025, it came in at $158.69 million, up 9.1% from FY2024.

  • Going back by year, Income towards Parent Company was $145.49 million in FY2024 (+12.9%), $128.85 million in FY2023 (-29.0%), $181.47 million in FY2022 (+424.5%) and $34.6 million in FY2021.
  • The Q2 2026 figure represents the highest quarterly Income towards Parent Company since Q3 2022.
  • Year-over-year, Income towards Parent Company increased in six of the last eight quarters, with growth averaging 48.1%.
  • The fastest year-over-year change in Income towards Parent Company over five years came in Q2 2025 (growth of 243.2%), and the weakest in Q2 2024 (a decline of 66.2%).
  • Business Quant data shows HRMY's Income towards Parent Company at $32.49 million (Q1 2026), $22.49 million (Q4 2025) and $50.87 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Harmony Biosciences Holdings 2.30 Bn -452.73 Mn 198.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 75.43 Mn
Mar 31, 2026 32.49 Mn
Dec 31, 2025 22.49 Mn
Sep 30, 2025 50.87 Mn
Jun 30, 2025 39.78 Mn
Mar 31, 2025 45.56 Mn
Dec 31, 2024 49.48 Mn
Sep 30, 2024 46.09 Mn
Jun 30, 2024 11.59 Mn
Mar 31, 2024 38.33 Mn
Dec 31, 2023 26.61 Mn
Sep 30, 2023 38.46 Mn
Jun 30, 2023 34.30 Mn
Mar 31, 2023 29.49 Mn
Dec 31, 2022 48.51 Mn
Sep 30, 2022 87.94 Mn
Jun 30, 2022 23.53 Mn
Mar 31, 2022 21.49 Mn
Dec 31, 2021 22.71 Mn
Sep 30, 2021 -9.62 Mn
API Access

Harmony Biosciences Holdings Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=HRMY&period=max&api_key=YOUR_API_KEY